These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 19514717)

  • 1. Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.
    Ali MM; Liu G; Shah T; Flask CA; Pagel MD
    Acc Chem Res; 2009 Jul; 42(7):915-24. PubMed ID: 19514717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging.
    Kim J; Wu Y; Guo Y; Zheng H; Sun PZ
    Contrast Media Mol Imaging; 2015; 10(3):163-178. PubMed ID: 25641791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring in vivo tumor pHe with CEST-FISP MRI.
    Sheth VR; Li Y; Chen LQ; Howison CM; Flask CA; Pagel MD
    Magn Reson Med; 2012 Mar; 67(3):760-8. PubMed ID: 22028287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.
    Chauvin T; Torres S; Rosseto R; Kotek J; Badet B; Durand P; Tóth E
    Chemistry; 2012 Jan; 18(5):1408-18. PubMed ID: 22213022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative description of radiofrequency (RF) power-based ratiometric chemical exchange saturation transfer (CEST) pH imaging.
    Wu R; Longo DL; Aime S; Sun PZ
    NMR Biomed; 2015 May; 28(5):555-65. PubMed ID: 25807919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-responsive paramagnetic CEST agents.
    Angelovski G; Chauvin T; Pohmann R; Logothetis NK; Tóth E
    Bioorg Med Chem; 2011 Feb; 19(3):1097-105. PubMed ID: 20691598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications.
    Aime S; Barge A; Delli Castelli D; Fedeli F; Mortillaro A; Nielsen FU; Terreno E
    Magn Reson Med; 2002 Apr; 47(4):639-48. PubMed ID: 11948724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
    Ali MM; Yoo B; Pagel MD
    Mol Pharm; 2009; 6(5):1409-16. PubMed ID: 19298054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.
    Woods M; Woessner DE; Sherry AD
    Chem Soc Rev; 2006 Jun; 35(6):500-11. PubMed ID: 16729144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents.
    Ferrauto G; Delli Castelli D; Di Gregorio E; Langereis S; Burdinski D; Grüll H; Terreno E; Aime S
    J Am Chem Soc; 2014 Jan; 136(2):638-41. PubMed ID: 24359116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEST and PARACEST MR contrast agents.
    Hancu I; Dixon WT; Woods M; Vinogradov E; Sherry AD; Lenkinski RE
    Acta Radiol; 2010 Oct; 51(8):910-23. PubMed ID: 20828299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI.
    Woessner DE; Zhang S; Merritt ME; Sherry AD
    Magn Reson Med; 2005 Apr; 53(4):790-9. PubMed ID: 15799055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.
    Liu G; Liang Y; Bar-Shir A; Chan KW; Galpoththawela CS; Bernard SM; Tse T; Yadav NN; Walczak P; McMahon MT; Bulte JW; van Zijl PC; Gilad AA
    J Am Chem Soc; 2011 Oct; 133(41):16326-9. PubMed ID: 21919523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.
    Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R
    J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-base porphyrins as CEST MRI contrast agents with highly upfield shifted labile protons.
    Zhang X; Yuan Y; Li S; Zeng Q; Guo Q; Liu N; Yang M; Yang Y; Liu M; McMahon MT; Zhou X
    Magn Reson Med; 2019 Aug; 82(2):577-585. PubMed ID: 30968442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lanthanide ion (III) complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaminophosphonate for dual biosensing of pH with chemical exchange saturation transfer (CEST) and biosensor imaging of redundant deviation in shifts (BIRDS).
    Huang Y; Coman D; Ali MM; Hyder F
    Contrast Media Mol Imaging; 2015; 10(1):51-8. PubMed ID: 24801742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.
    Chahid B; Vander Elst L; Flament J; Boumezbeur F; Medina C; Port M; Muller RN; Lesieur S
    Contrast Media Mol Imaging; 2014; 9(6):391-9. PubMed ID: 24760773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsive MRI agents for sensing metabolism in vivo.
    De Leon-Rodriguez LM; Lubag AJ; Malloy CR; Martinez GV; Gillies RJ; Sherry AD
    Acc Chem Res; 2009 Jul; 42(7):948-57. PubMed ID: 19265438
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.